LCD_LYCCL
ID LCD_LYCCL Reviewed; 766 AA.
AC A0A125SXN2;
DT 07-NOV-2018, integrated into UniProtKB/Swiss-Prot.
DT 13-APR-2016, sequence version 1.
DT 25-MAY-2022, entry version 20.
DE RecName: Full=Alpha-onocerin synthase LCD {ECO:0000303|PubMed:26663356};
DE EC=5.4.99.66 {ECO:0000269|PubMed:26663356};
GN Name=LCD {ECO:0000303|PubMed:26663356};
OS Lycopodium clavatum (Stag's-horn clubmoss).
OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC Lycopodiopsida; Lycopodiales; Lycopodiaceae; Lycopodioideae; Lycopodium.
OX NCBI_TaxID=3252;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX PubMed=26663356; DOI=10.1002/cbic.201500663;
RA Araki T., Saga Y., Marugami M., Otaka J., Araya H., Saito K., Yamazaki M.,
RA Suzuki H., Kushiro T.;
RT "Onocerin biosynthesis requires two highly dedicated triterpene cyclases in
RT a fern Lycopodium clavatum.";
RL ChemBioChem 17:288-290(2016).
CC -!- FUNCTION: Oxidosqualene cyclase involved in the biosynthesis of alpha-
CC onocerin, a triterpenoid characterized by a symmetrical structure due
CC to cyclizations at both termini of dioxidosqualene that inhibits
CC acetylcholinesterase. Catalyzes the second half of the cyclization,
CC exclusively from pre-alpha-onocerin. {ECO:0000269|PubMed:26663356}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=pre-alpha-onocerin = alpha-onocerin; Xref=Rhea:RHEA:54668,
CC ChEBI:CHEBI:138303, ChEBI:CHEBI:138305; EC=5.4.99.66;
CC Evidence={ECO:0000269|PubMed:26663356};
CC -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC {ECO:0000269|PubMed:26663356}.
CC -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; LC053636; BAU46472.1; -; mRNA.
DR AlphaFoldDB; A0A125SXN2; -.
DR SMR; A0A125SXN2; -.
DR KEGG; ag:BAU46472; -.
DR BRENDA; 5.4.99.66; 3106.
DR UniPathway; UPA00213; -.
DR GO; GO:0005811; C:lipid droplet; IEA:InterPro.
DR GO; GO:0016866; F:intramolecular transferase activity; IEA:InterPro.
DR GO; GO:0016104; P:triterpenoid biosynthetic process; IDA:UniProtKB.
DR CDD; cd02892; SQCY_1; 1.
DR InterPro; IPR032696; SQ_cyclase_C.
DR InterPro; IPR032697; SQ_cyclase_N.
DR InterPro; IPR018333; Squalene_cyclase.
DR InterPro; IPR002365; Terpene_synthase_CS.
DR InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR PANTHER; PTHR11764; PTHR11764; 1.
DR Pfam; PF13243; SQHop_cyclase_C; 1.
DR Pfam; PF13249; SQHop_cyclase_N; 1.
DR SUPFAM; SSF48239; SSF48239; 2.
DR TIGRFAMs; TIGR01787; squalene_cyclas; 1.
DR PROSITE; PS01074; TERPENE_SYNTHASES; 1.
PE 1: Evidence at protein level;
KW Isomerase; Repeat.
FT CHAIN 1..766
FT /note="Alpha-onocerin synthase LCD"
FT /id="PRO_0000445705"
FT REPEAT 101..143
FT /note="PFTB 1"
FT /evidence="ECO:0000255"
FT REPEAT 151..192
FT /note="PFTB 2"
FT /evidence="ECO:0000255"
FT REPEAT 456..507
FT /note="PFTB 3"
FT /evidence="ECO:0000255"
FT REPEAT 517..558
FT /note="PFTB 4"
FT /evidence="ECO:0000255"
FT REPEAT 594..634
FT /note="PFTB 5"
FT /evidence="ECO:0000255"
FT REPEAT 643..684
FT /note="PFTB 6"
FT /evidence="ECO:0000255"
FT REPEAT 705..752
FT /note="PFTB 7"
FT /evidence="ECO:0000255"
FT ACT_SITE 488
FT /note="Proton donor"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 421
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 615
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
SQ SEQUENCE 766 AA; 87194 MW; 5F87C4E324A997ED CRC64;
MWRLRTGSST VDKADSWLSS LNNHLGRQIW CYDPEAGTPQ EREAVEAECA RFTANRHQQR
QSADTLLRLQ FQKEHSANRL PSRITVNEDH EVTEDDVTTT LCRALQFYSQ LQTDDGHWSG
DHSGPMFFLP GMVIALYVTG ALDSVLSEHH QREICRYIYN HQRQDGSWGL HPEGTGTLFG
TVLSYVTLRL MGESKSNSNN REALRKAQTW IIDHGGATDV PSWGKFWLAV LGVYEWSGVN
PLPPESWLLP KSLIAHPGRL PVLYRFIFLP MSYIYARRLS HHLTKIIEDL RKELYTIPYE
DIDWNHARKL GAKEEIVPRS VVQDVILSIL HNYVEPIMSH WPGFLLRQKA LALIMEHIHH
EDETTQYLCV CPVSKALNML CCWLEDRNSD AFKKHLSRVL DFLWLSEDGM KMQVCNGSQL
WDTALSVRAL ISANLLNECS SMLRRAKLYI ENTQIQESYP GDLDHWHRIT SKGGWPQSTR
DWGWPVSDCT AEALQAVLAL SSQSTTDVGE ALPEERIHEC INVLLSFQKS NGSFAPFDAR
NPLEGPKIWN HTESPGYKSL DFECVECTSS VIQALAAFNK IYPEHRAKEI SISIQEGTRF
IERLQNSDGS WSGTWGICFT YATWFGIMGL LASGARYYES IAIQRACEFI LSKQLPNGGW
GEHFHSFKNK VYTNLEGERA HVVHTSWSML ALLATGQEGR DAIPLHRAAK ILINAQMETG
DYSQEGVVGA VCGDHTISYA TYRCVFPIWA LGEYRYKLFG KKNMYI